BioCentury | Feb 8, 2019
Product R&D

Reducing R(i)SK in TNBC

...patients. Breast cancer patients already have a biopsy taken for immunostaining, commonly on a Roche Ventana...
BioCentury | Nov 30, 2018
Company News

Roche launches pan-Trk diagnostic

...Roche (SIX:ROG; OTCQX:RHHBY) launched its Ventana pan-TRK (EPR17341) assay to detect tropomyosin receptor kinase (Trk) proteins...
...all three Trk proteins, A, B and C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Chris Lieu Roche Ventana...
BioCentury | Aug 4, 2017
Clinical News

Roche's Ventana approved as companion diagnostic for Novartis' Zykadia

...In June, Roche (SIX:ROG; OTCQX:RHHBY) said FDA approved Ventana ALK (D5F3) CDx Assay as a companion...
...Pfizer and Cell Signaling Technology Inc. (Danvers, Mass.) to develop the test based on Ventana’s Ventana...
...York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana ALK (D5F3) CDx Assay Business: Diagnostic Alex Himes Ventana...
BioCentury | May 31, 2017
Clinical News

CE Mark approval granted for Roche's Keytruda companion diagnostic

...Roche (SIX:ROG; OTCQX:RHHBY) received CE Mark approval for its Ventana PD-L1 (SP263) Assay to identify metastatic...
...Keytruda. Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Bristol-Myers Squibb Co. (NYSE:BMY) share rights to Opdivo. Ventana...
...enhance and score PD-L1 protein on tumor-infiltrating immune cells. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana...
BioCentury | Mar 24, 2017
Company News

Loxo, Roche deal

...Loxo and Roche's Ventana Medical Systems Inc. unit partnered to develop and commercialize a pan-neurotrophic tyrosine...
BioCentury | Mar 17, 2017
Tools & Techniques

Calibrating PD-L1

...Dako A/S unit of Agilent Technologies Inc. The SP142 and SP263 assays are from Roche’s Ventana...
...Dako A/S unit of Agilent Technologies Inc. (NYSE:A), while the SP142 assay is from the Ventana...
BioCentury | Feb 23, 2017
Clinical News

Roche PD-L1 assay not concordant with others

...the comparison study is a Blueprint participant, along with FDA, EMA and research organizations. The Ventana...
...from the study will be presented Friday at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando. Becky Simon Ventana...
BioCentury | Nov 2, 2016
Clinical News

Ventana PD-L1 regulatory update

...FDA approved Roche’s Ventana PD-L1 Assay as a complementary diagnostic to assess PD-L1 expression levels in...
...San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana PD-L1 (SP142) Assay Business: Diagnostic Julian Zhu Tecentriq Ventana...
BioCentury | Oct 17, 2016
Product Development

Yes we PanCAN

...whose tumor biopsies show high levels of hyaluronan using a developmental-stage companion diagnostic from Roche's Ventana...
BioCentury | Aug 22, 2016
Product Development

The devil is in the assay

...Research (AACR), the International Association for the Study of Lung Cancer (IASLC), FDA, EMA, Roche's Ventana...
...which have not yet been disclosed. In the first phase of Blueprint, the Dako and Ventana...
...Ventana Medical Systems Inc. to develop an assay for Tecentriq atezolizumab. AstraZeneca plc also tapped Ventana...
Items per page:
1 - 10 of 135
BioCentury | Feb 8, 2019
Product R&D

Reducing R(i)SK in TNBC

...patients. Breast cancer patients already have a biopsy taken for immunostaining, commonly on a Roche Ventana...
BioCentury | Nov 30, 2018
Company News

Roche launches pan-Trk diagnostic

...Roche (SIX:ROG; OTCQX:RHHBY) launched its Ventana pan-TRK (EPR17341) assay to detect tropomyosin receptor kinase (Trk) proteins...
...all three Trk proteins, A, B and C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Chris Lieu Roche Ventana...
BioCentury | Aug 4, 2017
Clinical News

Roche's Ventana approved as companion diagnostic for Novartis' Zykadia

...In June, Roche (SIX:ROG; OTCQX:RHHBY) said FDA approved Ventana ALK (D5F3) CDx Assay as a companion...
...Pfizer and Cell Signaling Technology Inc. (Danvers, Mass.) to develop the test based on Ventana’s Ventana...
...York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana ALK (D5F3) CDx Assay Business: Diagnostic Alex Himes Ventana...
BioCentury | May 31, 2017
Clinical News

CE Mark approval granted for Roche's Keytruda companion diagnostic

...Roche (SIX:ROG; OTCQX:RHHBY) received CE Mark approval for its Ventana PD-L1 (SP263) Assay to identify metastatic...
...Keytruda. Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Bristol-Myers Squibb Co. (NYSE:BMY) share rights to Opdivo. Ventana...
...enhance and score PD-L1 protein on tumor-infiltrating immune cells. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana...
BioCentury | Mar 24, 2017
Company News

Loxo, Roche deal

...Loxo and Roche's Ventana Medical Systems Inc. unit partnered to develop and commercialize a pan-neurotrophic tyrosine...
BioCentury | Mar 17, 2017
Tools & Techniques

Calibrating PD-L1

...Dako A/S unit of Agilent Technologies Inc. The SP142 and SP263 assays are from Roche’s Ventana...
...Dako A/S unit of Agilent Technologies Inc. (NYSE:A), while the SP142 assay is from the Ventana...
BioCentury | Feb 23, 2017
Clinical News

Roche PD-L1 assay not concordant with others

...the comparison study is a Blueprint participant, along with FDA, EMA and research organizations. The Ventana...
...from the study will be presented Friday at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando. Becky Simon Ventana...
BioCentury | Nov 2, 2016
Clinical News

Ventana PD-L1 regulatory update

...FDA approved Roche’s Ventana PD-L1 Assay as a complementary diagnostic to assess PD-L1 expression levels in...
...San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana PD-L1 (SP142) Assay Business: Diagnostic Julian Zhu Tecentriq Ventana...
BioCentury | Oct 17, 2016
Product Development

Yes we PanCAN

...whose tumor biopsies show high levels of hyaluronan using a developmental-stage companion diagnostic from Roche's Ventana...
BioCentury | Aug 22, 2016
Product Development

The devil is in the assay

...Research (AACR), the International Association for the Study of Lung Cancer (IASLC), FDA, EMA, Roche's Ventana...
...which have not yet been disclosed. In the first phase of Blueprint, the Dako and Ventana...
...Ventana Medical Systems Inc. to develop an assay for Tecentriq atezolizumab. AstraZeneca plc also tapped Ventana...
Items per page:
1 - 10 of 135